Report Detail
Global Japanese Encephalitis Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3671670 |
- 16 August, 2019 |
- Global |
- 122 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Epidemic encephalitis (JE) is a disease spreads through mosquito bites. Symptoms usually take 5-15 days to develop and include fever, headache, vomiting, confusion, and difficulty moving. The major form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very common, especially among children (up to 50%). Prevention is possible through the use of inactivated vaccines.
Scope of the Report:
The worldwide market for Japanese Encephalitis Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Japanese Encephalitis Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
China National Biotec Group
Valneva Products
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Attenuated Vaccines
Inactivated Vaccines
Market Segment by Applications, can be divided into
Adults
Children
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Japanese Encephalitis Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Japanese Encephalitis Vaccines, with price, sales, revenue and global market share of Japanese Encephalitis Vaccines in 2017 and 2018.
Chapter 3, the Japanese Encephalitis Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Japanese Encephalitis Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Japanese Encephalitis Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Japanese Encephalitis Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Japanese Encephalitis Vaccines Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Attenuated Vaccines
- 1.2.2 Inactivated Vaccines
- 1.3 Market Analysis by Applications
- 1.3.1 Adults
- 1.3.2 Children
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Sanofi Pasteur
- 2.1.1 Business Overview
- 2.1.2 Japanese Encephalitis Vaccines Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 GlaxoSmithKline
- 2.2.1 Business Overview
- 2.2.2 Japanese Encephalitis Vaccines Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Bharat Biotech
- 2.3.1 Business Overview
- 2.3.2 Japanese Encephalitis Vaccines Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 China National Biotec Group
- 2.4.1 Business Overview
- 2.4.2 Japanese Encephalitis Vaccines Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Valneva Products
- 2.5.1 Business Overview
- 2.5.2 Japanese Encephalitis Vaccines Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Valneva Products Japanese Encephalitis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Japanese Encephalitis Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Japanese Encephalitis Vaccines Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Japanese Encephalitis Vaccines Manufacturer Market Share in 2018
- 3.3.2 Top 6 Japanese Encephalitis Vaccines Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Japanese Encephalitis Vaccines Market Analysis by Regions
- 4.1 Global Japanese Encephalitis Vaccines Sales, Revenue and Market Share by Regions
- 4.1.1 Global Japanese Encephalitis Vaccines Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 4.3 Europe Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 4.5 South America Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
5 North America Japanese Encephalitis Vaccines by Country
- 5.1 North America Japanese Encephalitis Vaccines Sales, Revenue and Market Share by Country
- 5.1.1 North America Japanese Encephalitis Vaccines Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Japanese Encephalitis Vaccines Revenue and Market Share by Country (2014-2019)
- 5.2 United States Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 5.3 Canada Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 5.4 Mexico Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
6 Europe Japanese Encephalitis Vaccines by Country
- 6.1 Europe Japanese Encephalitis Vaccines Sales, Revenue and Market Share by Country
- 6.1.1 Europe Japanese Encephalitis Vaccines Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Japanese Encephalitis Vaccines Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 6.3 UK Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 6.4 France Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 6.5 Russia Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 6.6 Italy Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Japanese Encephalitis Vaccines by Country
- 7.1 Asia-Pacific Japanese Encephalitis Vaccines Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Japanese Encephalitis Vaccines Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Japanese Encephalitis Vaccines Revenue and Market Share by Country (2014-2019)
- 7.2 China Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 7.3 Japan Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 7.4 Korea Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 7.5 India Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
8 South America Japanese Encephalitis Vaccines by Country
- 8.1 South America Japanese Encephalitis Vaccines Sales, Revenue and Market Share by Country
- 8.1.1 South America Japanese Encephalitis Vaccines Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Japanese Encephalitis Vaccines Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 8.3 Argentina Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 8.4 Colombia Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Japanese Encephalitis Vaccines by Countries
- 9.1 Middle East and Africa Japanese Encephalitis Vaccines Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Japanese Encephalitis Vaccines Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Japanese Encephalitis Vaccines Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 9.3 Turkey Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 9.4 Egypt Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
- 9.6 South Africa Japanese Encephalitis Vaccines Sales and Growth Rate (2014-2019)
10 Global Japanese Encephalitis Vaccines Market Segment by Type
- 10.1 Global Japanese Encephalitis Vaccines Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Japanese Encephalitis Vaccines Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Japanese Encephalitis Vaccines Revenue and Market Share by Type (2014-2019)
- 10.2 Attenuated Vaccines Sales Growth and Price
- 10.2.1 Global Attenuated Vaccines Sales Growth (2014-2019)
- 10.2.2 Global Attenuated Vaccines Price (2014-2019)
- 10.3 Inactivated Vaccines Sales Growth and Price
- 10.3.1 Global Inactivated Vaccines Sales Growth (2014-2019)
- 10.3.2 Global Inactivated Vaccines Price (2014-2019)
11 Global Japanese Encephalitis Vaccines Market Segment by Application
- 11.1 Global Japanese Encephalitis Vaccines Sales Market Share by Application (2014-2019)
- 11.2 Adults Sales Growth (2014-2019)
- 11.3 Children Sales Growth (2014-2019)
12 Japanese Encephalitis Vaccines Market Forecast (2019-2024)
- 12.1 Global Japanese Encephalitis Vaccines Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Japanese Encephalitis Vaccines Market Forecast by Regions (2019-2024)
- 12.2.1 North America Japanese Encephalitis Vaccines Market Forecast (2019-2024)
- 12.2.2 Europe Japanese Encephalitis Vaccines Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Japanese Encephalitis Vaccines Market Forecast (2019-2024)
- 12.2.4 South America Japanese Encephalitis Vaccines Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Japanese Encephalitis Vaccines Market Forecast (2019-2024)
- 12.3 Japanese Encephalitis Vaccines Market Forecast by Type (2019-2024)
- 12.3.1 Global Japanese Encephalitis Vaccines Sales Forecast by Type (2019-2024)
- 12.3.2 Global Japanese Encephalitis Vaccines Market Share Forecast by Type (2019-2024)
- 12.4 Japanese Encephalitis Vaccines Market Forecast by Application (2019-2024)
- 12.4.1 Global Japanese Encephalitis Vaccines Sales Forecast by Application (2019-2024)
- 12.4.2 Global Japanese Encephalitis Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Japanese Encephalitis Vaccines. Industry analysis & Market Report on Japanese Encephalitis Vaccines is a syndicated market report, published as Global Japanese Encephalitis Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Japanese Encephalitis Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
